Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Single-center experience of long-term outcomes of AL amyloidosis patients receiving heart transplant finds 1-, 3-, 5-, and 8-year survival (87%, 83%, 73%, and 67%) not different vs. non-AL patients (92%, 85%, 79%, 68%).”
Title: Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience
Authors: Khush Patel, Zoe H. Tu, Carrie Yuen, Siddhartha Ganguly, Allison N. Yun, Janardhana R. Gorthi, Barry H. Trachtenberg, Ashrith Guha, Mahwash Kassi, Ju Kim, Rayan Yousefzai, Kelty Baker, Lawrence Rice, Rammurti T. Kamble, Horacio E. Adrogue, Erik E. Suarez, Mark Ghobrial, Ashish Saharia, Constance M. Mobley, David W. Victor, Jill C. Krisl, Richard Knight, A. Osama Gaber, Arvind Bhimaraj.
You can read the Full Article in JHLT Open.
You can find more posts featuring Robert Orlowski in OncoDaily.
